BMC neurology
Urinary proteomic profiling reveals diagnostic biomarkers and regulatory networks in myasthenia gravis.
Jing Yang, Xi Yang, Zhen-Kun Zhu, Liang Shen, Shi-Ge San, Lianchen Xiao, Fan Ye, Chun-Hua Wang, Kun Meng
Published: 202610.1186/s12883-025-04623-5
Abstract
BACKGROUND: Myasthenia gravis (MG) is a chronic autoimmune neuromuscular junction disorder mediated by autoantibodies. Existing diagnostic methods mainly rely on serum antibody detection and electrophysiological testing, which are limited by invasive…
Preview only. Read the full abstract at the source